Guardant Health
GH
#1154
Rank
A$29.30 B
Marketcap
A$216.62
Share price
1.30%
Change (1 day)
47.54%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): A-$5.14

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is A-$5.21. In 2025 the company made an earnings per share (EPS) of A-$4.94 an increase over its 2024 EPS that were of A-$5.31.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$5.144.1%
2025A-$4.94-7.02%
2024A-$5.31-16.82%
2023A-$6.39-33.12%
2022A-$9.5560%
2021A-$5.9755.04%
2020A-$3.85207.14%
2019A-$1.25-19.81%
2018A-$1.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
A-$0.38-92.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
A-$3.66-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA